Chemotherapy for advanced gastric cancer: review of global and Japanese status.
about
Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cellsAdvanced gastric cancer: an update and future directionsChemotherapy for advanced gastric cancer: a new milestone lies ahead.Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a']diisoquinoline Derivative and Its Synergistic Action with Nigella sativa in Human Gastric Cancer Cells.TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.
P2860
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@en
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@nl
type
label
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@en
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@nl
prefLabel
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@en
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
@nl
P2860
P1476
Chemotherapy for advanced gastric cancer: review of global and Japanese status
@en
P2093
Wasaburo Koizumi
P2860
P304
P577
2007-09-01T00:00:00Z